The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
UPDATE ON DRUG RESISTANCE MUTATIONS IN HIV-1
Abstract
UPDATE ON DRUG RESISTANCE MUTATIONS IN HIV-1 [D’Aquila RT, et al.Topics in HIV Med2001;9:31]: The “Resistance Mutations Project panel” has provided updated recommendations for interpreting resistance tests. Major changes are summarized below: There is no longer a distinction between primary and secondary resistance mutations in the reverse transcriptase gene. The rationale is based on the observation that the sequence of evolution and the contribution to total resistance is debated for these mutations. However, the distinction between primary and secondary mutations will be retained for the protease gene because these correlate with the magnitude of resistance. The nucleotide RT inhibitor, tenofovir, has been added. The resistance gene is K65R. Mutations that confer resistance to lopinavir have been added. These are all secondary mutations and include those at codons 10, 20, 24, 46, 53, 54, 71, 82, 84, and 90. There is now the addition of the “multi-protease inhibitor resistance,” in which the primary mutations are at codons 46, 82, 84, and 90. Additional information is available from http://www.iasusa.org.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multi-step inhibition explains HIV-1 protease inhibitor pharmacodynamics and resistance
Rabi, S. A., Laird, G. M., Durand, C. M., Laskey, S. B., Shan, L., Bailey, J. R., Chioma, S., Moore, R. D., & Siliciano, R. F. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67399 · Cited by 146
Cited by
Approved Antiviral Drugs over the Past 50 Years
De Clercq, E., & Li, G. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-15 · Cited by 1,430
Treatment for Adult HIV Infection: 2006 Recommendations of the International AIDS Society–USA Panel
Hammer, S. M., Saag, M. S., Schechter, M., Montaner, J. S. G., Schooley, R. T., Jacobsen, D. M., Thompson, M. A., Carpenter, C. C. J., Fischl, M. A., Gazzard, B. G., et al. (2006) · JAMA · doi:10.1001/jama.296.7.827 · Cited by 1,033
Domingo, E., Sheldon, J., & Perales, C. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05023-11 · Cited by 1,009
Class-Sparing Regimens for Initial Treatment of HIV-1 Infection
Riddler, S. A., Haubrich, R., DiRienzo, A. G., Peeples, L., Powderly, W. G., Klingman, K. L., Garren, K. W., George, T., Rooney, J. F., Brizz, B., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa074609 · Cited by 680
Web Resources for HIV Type 1 Genotypic-Resistance Test Interpretation
Liu, T. F., & Shafer, R. W. (2006) · Clinical Infectious Diseases · doi:10.1086/503914 · Cited by 654
Metadata
- Authors
- &NA;
- Venue
- Infectious Diseases in Clinical Practice
- Published
- 2001-06
- Volume
- 10
- Issue
- 5
- Pages
- 287
- ISSN
- 1056-9103 (ISSN-L)
- OpenAlex
- W4236479494
- Cited by
- 1,660
- References
- 1
- FWCI
- 0.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: UPDATE ON DRUG RESISTANCE MUTATIONS IN HIV-1. https://app.cochat.ai/papers/10.1097/00019048-200106000-00020
- The paper
- &NA;. (2001). UPDATE ON DRUG RESISTANCE MUTATIONS IN HIV-1. Infectious Diseases in Clinical Practice. https://doi.org/10.1097/00019048-200106000-00020
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.